The Beachbody Company, Inc.

NYSE:BODY

8.14 (USD) • At close March 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Revenue 418.796527.109692.199873.645863.582755.779790.289
Cost of Revenue 131.452204.022322.626328.662249.707210.319228.915
Gross Profit 287.344323.087369.573544.983613.875545.46561.374
Gross Profit Ratio 0.6860.6130.5340.6240.7110.7220.71
Reseach & Development Expenses 76.3774.407104.363119.91593.03684.13291.189
General & Administrative Expenses 49.1957.93278.42679.68264.81856.89963.096
Selling & Marketing Expenses 200.145282.147359.987548.13464384.376401.141
SG&A 249.335340.079438.413627.812528.818441.275464.237
Other Expenses 01.7470.9583.2040.6660.8130.991
Operating Expenses 325.705414.486542.776747.727621.854525.407555.426
Operating Income -38.361-91.399-173.203-202.744-7.31318.882-0.607
Operating Income Ratio -0.092-0.173-0.25-0.232-0.0080.025-0.001
Total Other Income Expenses Net -33.042-61.205-24.042-41.1771.15-2-5.832
Income Before Tax -71.403-152.604-197.245-243.921-6.16318.9050.116
Income Before Tax Ratio -0.17-0.29-0.285-0.279-0.0070.0250
Income Tax Expense -0.2390.037-3.053-15.53915.269-13.390.991
Net Income -71.642-152.641-194.192-228.382-21.43232.2950.116
Net Income Ratio -0.171-0.29-0.281-0.261-0.0250.0430
EPS -10.51-24.47-0.63-0.83-0.070.110
EPS Diluted -10.51-24.47-0.63-0.83-0.070.110
EBITDA -38.361-26.324-74.079-139.94336.94465.52559.426
EBITDA Ratio -0.092-0.05-0.107-0.160.0430.0870.075